Latest News

  • Precision Oncology Facing Inequities and Acceptance Issues

    Diagnostics World News | Precision medicine promises treatment strategies tailored to individual patient characteristics and tumor biology. But improved health outcomes won’t happen without access to healthcare and molecular testing, which can differ substantially by geography and even within individual countries.

    Nov 1, 2019
  • Illumina, QIAGEN, Optibrium, and More: News From October 2019

    Diagnostics World News | October featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Illumina, QIAGEN, Optibrium, and more.

    Oct 31, 2019
  • Overcoming Obstacles With Liquid Biopsies

    Diagnostics World News | The value of liquid biopsies in precision medicine, particularly for managing cancers where tissue samples from tumors and metastatic sites are hard if not impossible to obtain, is a major topic of conversation, as tests that look for circulating tumor cells and circulating tumor DNA are enjoying a "resurgence" in clinical trials.

    Oct 29, 2019
  • Dopamine Detection Device Offers Faster and Direct Detection

    Diagnostics World News | The world of medicine is continually seeking new methods to improve health outcomes through a variety of innovative mechanisms, and accelerated diagnostics is no exception. Now, scientists may have a faster, easier way to diagnose and catch certain diseases earlier thanks to a new dopamine detector.

    Oct 24, 2019
  • Mixed Opinions On How To Regulate Laboratory Developed Tests

    Diagnostics World News | A trio of sessions at the 2019 Next Generation Dx Summit in August focused on laboratory developed tests (LDTs)—in vitro diagnostic tests designed, manufactured and used within a single laboratory—and incited lively debate about proposed regulation under the VALID Act.

    Oct 22, 2019
  • Engineered Viruses Could Fight Drug Resistance

    MIT News | MIT biological engineers can program bacteriophages to kill different strains of E. coli by making mutations in the protein that the viruses use to bind to host cells. These engineered phages are less likely to provoke resistance in bacteria, and could help to overcome antibiotic resistance.

    Oct 21, 2019
  • Sensors in Diagnostics: A Preview of the Sensors Summit

    Diagnostics World News | Sensors are revolutionizing healthcare and the presenters at the Sensors Summit 2019 are taking three days to show just how much.

    Oct 17, 2019
  • Working Out The Riddles Of Adaptive Machine Learning

    Diagnostics World News | At the 2019 Next Generation Dx Summit in August, a staff fellow with the FDA shared the agency's approach to evaluating medical devices enabled by "adaptive" artificial intelligence and machine learning—meaning they continuously learn as they're exposed to more data.

    Oct 16, 2019